Trial Profile
A Single-Center, Retrospective, Non-Comparative Study Investigating Aflibercept in Patients with Diabetic Macular Edema (DME) Treated with Prior Ranibizumab and/or Bevacizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 26 Jul 2017 New trial record